K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratificationAndrew S. Levey, Antonio M. Gotto, Cynda Ann Johnson et al.|Data Archiving and Networked Services (DANS)|2002Cited by 11.7k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and StratificationAndrew S. Levey, Garabed Eknoyan, Josef Coresh et al.|Annals of Internal Medicine|2003Cited by 4.6k
Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic AdultsElizabeth Selvin, Frederick L. Brancati, Michael W. Steffes et al.|New England Journal of Medicine|2010Cited by 1.6k
Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2Lesley A. Stevens, Andrew S. Levey, Christopher H. Schmid et al.|American Journal of Kidney Diseases|2010Cited by 599
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic ratThorsten P. Degenhardt, John Baynes, Nathan L. Alderson et al.|Kidney International|2002Cited by 377